ELISA Inter-Plate Variability: Same Sample, Different Results
Quick answer
On the Dog Beta-endorphin (BEP) ELISA Kit, a researcher ran the same canine serum aliquots on two plates from the same lot and saw roughly double the concentration on one plate versus the other. The standard curves on every run were valid and the lot’s QC precision was strong (inter-assay CV ≈ 6.8%), so the kit chemistry was working. The discrepancy traced to sample-level handling and an undiluted-serum matrix effect on a single run — not a kit fault. Diluting serum into the mid-range of the curve and tightening pipetting resolved it.
On this page
Click any section below to jump straight to it ↓
The problem
To check reproducibility across plates, a researcher split each canine serum sample into two aliquots and ran them in parallel on two plates from the same lot of the Dog Beta-endorphin (BEP) ELISA, quantifying with a four-parameter logistic (4PL) curve. Two samples returned roughly double the concentration on one plate compared with the other, even though the serum was identical. A third repeated sample, by contrast, agreed closely between the two plates. The question was clear: with the same serum and the same lot, how could one plate read twice as high as another?
Snapshot of the data
The telling pattern is that the disagreement was sample-specific. Two samples diverged by about two-fold between plates, while a third repeated sample stayed consistent — a strong hint that the effect lived in individual samples, not in the plate or the curve.
| Serum sample | Plate 1 (4PL), pg/mL | Plate 2 (4PL), pg/mL | Between-plate agreement |
| Sample A | ≈ 160 | ≈ 68 | ∼2.4× discrepancy |
| Sample B | ≈ 450 | ≈ 194 | ∼2.3× discrepancy |
| Sample C (control repeat) | ≈ 138 | ≈ 187 | Consistent (within range) |
| Quality check | Result | Interpretation |
| Standard curves (all runs) | Clean, well-fitted 4PL | Kit chemistry working correctly |
| Lot inter-assay CV (QC) | ≈ 6.8% | Well under the <10% target |
| Detection range (datasheet) | 15.6–1000 pg/mL | High samples sat near the top of the curve |
Customer and sample identities are anonymized; values are illustrative of the reported pattern.
Why the same sample can read differently across plates
When the standard curve is valid but one sample varies between plates, the cause almost always sits at the sample level rather than in the kit. Three factors dominate: a matrix effect from undiluted serum, where sample-to-sample differences in composition shift the apparent signal; readings that land near the steep top or bottom of the 4PL curve, where a tiny change in optical density becomes a large change in back-calculated concentration; and small pipetting or handling inconsistencies that widen replicate scatter. A sample sitting comfortably in the middle of the curve, like the consistent repeat here, is buffered against all three — which is exactly why it agreed.
Our analysis
We started from what was solid. The standard curves on every run were clean and well-fitted, and the lot’s QC inter-assay CV was about 6.8% — comfortably inside the <10% target (up to 20% is acceptable). The capture-and-detection chemistry was therefore working as designed. The consistent third sample confirmed the assay reproduces well when a reading sits in the middle of the curve.
The two discordant samples told a different story. Their replicate CVs were elevated on both plates, and both had been measured undiluted — one high enough to sit near the upper plateau of the curve, the other low enough to give a weak optical density near the bottom. Both are regions where a 4PL curve is least precise. Crucially, a later re-test with a fresh kit reproduced the lower plate’s values, isolating the inflated readings to one particular run rather than to the kit or the lot.
Root cause
The inter-plate discrepancy came from sample-level handling and an undiluted-serum matrix effect on a single run — not from the kit. Valid standard curves and a strong lot QC precision (inter-assay CV ≈ 6.8%) confirmed the chemistry, and the inflated values were confined to one plate and did not reproduce on retest.
What we recommended
Because the assay itself was sound, the fix is to keep every sample reading in the reliable part of the curve and to remove handling variability:
- Run a full standard curve on every plate, so each run is validated independently and plates can be compared with confidence.
- Pre-test a few representative samples at several dilutions (for example 1:2 to 1:3) in the kit sample diluent, and choose the dilution that lands optical densities in the mid, linear portion of the curve while confirming acceptable linearity.
- Dilute serum to minimise matrix effects and pull high samples away from the upper plateau; avoid reporting values read at the very top or bottom of the curve.
- Standardise handling: centrifuge and mix samples, keep volumes and tip position consistent, avoid bubbles and contact with the well wall, wash thoroughly without overflow, never reuse plate seals, and keep pipettes calibrated.
Key takeaway
When one sample disagrees across plates but the standard curves and QC are solid, look at the sample, not the kit: dilute into the mid-range of the curve, keep handling consistent, and re-test to confirm. For more guidance, see our ELISA Support Hub →
Frequently asked questions
What inter-assay CV should I expect from this kit?
Our target is an inter-assay CV below 10%, with up to 20% considered acceptable. The lot in this case returned about 6.8% in QC testing, so lot-level reproducibility was not the problem.
Same serum, two plates, very different values — is the kit faulty?
Not if the standard curves are valid and QC precision is in range. A sample-specific two-fold gap between plates usually points to handling, a matrix effect, or a reading near the extremes of the curve rather than a kit defect — especially when a co-run repeat sample stays consistent.
Why does a reading near the top of the curve matter?
A 4PL curve flattens at its top and bottom, so near those plateaus a small change in optical density translates into a large change in calculated concentration. Diluting the sample brings the reading into the steeper, mid-range portion where results are most reliable.
Should I dilute canine serum routinely for this assay?
Pre-test a few representative samples at several dilutions and pick the one that keeps optical densities mid-curve while confirming linearity. Validation targeted undiluted canine serum around 130 pg/mL, so samples reading much higher generally benefit from dilution.
Related reading
Explore more from our ELISA Support Hub — click to open:
Dog Beta-endorphin (BEP) ELISA Kit →
SKU: CNEB0155
| Detection range | 15.6–1000 pg/mL |
| Sensitivity | 3.9 pg/mL |
| Sample types | Serum, plasma, tissue homogenates, cell culture supernatants and other biological fluids |
Price: €749
View product →Seeing plate-to-plate variability in your ELISA?
Our PhD technical team reviews standard curves, OD tables and dilution strategies to get your assay reproducible again.
Contact Technical Support → ELISA Support Hub → Browse ELISA Kits →Written by the Assay Genie scientific team — reviewed for accuracy by our PhD scientists. Customer and sample identities have been anonymized; data values are illustrative of the reported pattern and provided for educational purposes.
Recent Posts
-
Antigen Processing and Presentation: MHC-I, MHC-II, Cross-Priming
Every T-cell response begins with a protein being taken apart. Before a CD8 or CD4 T cell can see a …20th Aug 2026 -
Apoptosis Pathway: Death Receptor, Mitochondrial and Granzyme Routes
Apoptosis is not one pathway but three routes into the same execution machinery. A death ligand at …20th Aug 2026 -
PI3K/AKT/mTOR Signalling in T Cells: Pathway, Function and Assays
PI3K does not switch on a protein — it rewrites a membrane. Everything downstream follows from one …20th Aug 2026